PET Imaging as a Tool for Assessing COVID-19 Brain Changes.


Journal

Trends in neurosciences
ISSN: 1878-108X
Titre abrégé: Trends Neurosci
Pays: England
ID NLM: 7808616

Informations de publication

Date de publication:
12 2020
Historique:
received: 15 10 2020
accepted: 19 10 2020
pubmed: 3 11 2020
medline: 15 12 2020
entrez: 2 11 2020
Statut: ppublish

Résumé

A substantial fraction of coronavirus disease 2019 (COVID-19) patients experience neurological manifestations. Nevertheless, brain changes caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remain largely unknown. Here, we provide a brief overview of positron emission tomography (PET) applications that could advance current understanding of CNS pathophysiological alterations associated with SARS-CoV-2 infection.

Identifiants

pubmed: 33131922
pii: S0166-2236(20)30243-5
doi: 10.1016/j.tins.2020.10.010
pmc: PMC7580682
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

935-938

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Références

Lancet Neurol. 2020 Oct;19(10):804-805
pubmed: 32949534
Q J Nucl Med Mol Imaging. 2017 Dec;61(4):414-428
pubmed: 28750497
J Exp Med. 2021 Mar 1;218(3):
pubmed: 33433624
Annu Rev Biomed Eng. 2019 Jun 4;21:551-581
pubmed: 31167104
N Engl J Med. 2020 Jun 4;382(23):2268-2270
pubmed: 32294339
Lancet. 2020 Mar 28;395(10229):1033-1034
pubmed: 32192578
Eur J Nucl Med Mol Imaging. 2021 Feb;48(2):592-595
pubmed: 32728799
Mol Imaging. 2018 Jan-Dec;17:1536012118792317
pubmed: 30203712
Brain. 2020 Oct 1;143(10):3104-3120
pubmed: 32637987
Eur J Neurol. 2020 Dec;27(12):2651-2657
pubmed: 32881133
Lancet Neurol. 2020 Nov;19(11):919-929
pubmed: 33031735
Radiology. 2020 Nov;297(2):E242-E251
pubmed: 32544034

Auteurs

Igor C Fontana (IC)

Graduate Program in Biological Sciences: Biochemistry, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil; School of Biomedical Engineering and Imaging Sciences, St Thomas' Hospital, King's College London, London SE1 7EH, UK.

Salvatore Bongarzone (S)

School of Biomedical Engineering and Imaging Sciences, St Thomas' Hospital, King's College London, London SE1 7EH, UK.

Antony Gee (A)

School of Biomedical Engineering and Imaging Sciences, St Thomas' Hospital, King's College London, London SE1 7EH, UK.

Diogo O Souza (DO)

Graduate Program in Biological Sciences: Biochemistry, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil; Department of Biochemistry, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.

Eduardo R Zimmer (ER)

Graduate Program in Biological Sciences: Biochemistry, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil; Department of Pharmacology, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil; Graduate Program in Biological Sciences: Pharmacology and Therapeutics, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil. Electronic address: eduardo.zimmer@ufrgs.br.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH